Testing effectiveness (Phase 2)Study completedNCT00889382
What this trial is testing
A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Who this might be right for
Ovarian CancerSolid Tumors
Astellas Pharma Inc 152